LPL Financial LLC increased its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 5.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 129,414 shares of the technology company's stock after acquiring an additional 6,399 shares during the quarter. LPL Financial LLC owned approximately 0.11% of Amdocs worth $11,841,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in the business. Councilmark Asset Management LLC bought a new position in shares of Amdocs during the first quarter valued at about $205,000. HB Wealth Management LLC boosted its position in shares of Amdocs by 35.5% in the first quarter. HB Wealth Management LLC now owns 5,202 shares of the technology company's stock valued at $476,000 after acquiring an additional 1,363 shares during the period. Cetera Investment Advisers lifted its position in Amdocs by 17.3% during the first quarter. Cetera Investment Advisers now owns 61,640 shares of the technology company's stock valued at $5,640,000 after purchasing an additional 9,072 shares during the last quarter. Avantax Advisory Services Inc. lifted its position in Amdocs by 4.8% during the first quarter. Avantax Advisory Services Inc. now owns 11,116 shares of the technology company's stock valued at $1,017,000 after purchasing an additional 511 shares during the last quarter. Finally, Tempus Wealth Planning LLC lifted its holdings in shares of Amdocs by 7.3% in the 1st quarter. Tempus Wealth Planning LLC now owns 5,490 shares of the technology company's stock worth $502,000 after acquiring an additional 373 shares during the last quarter. 92.02% of the stock is owned by institutional investors.
Amdocs Price Performance
DOX opened at $88.87 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.16 and a current ratio of 1.16. The stock has a market capitalization of $10.03 billion, a P/E ratio of 18.03, a P/E/G ratio of 1.40 and a beta of 0.51. The company's 50-day simple moving average is $90.22 and its two-hundred day simple moving average is $88.69. Amdocs Limited has a 52-week low of $78.61 and a 52-week high of $95.41.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, beating the consensus estimate of $1.71 by $0.01. Amdocs had a net margin of 11.94% and a return on equity of 19.72%. The firm had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.13 billion. During the same quarter in the prior year, the firm earned $1.62 EPS. The business's revenue for the quarter was down 8.4% compared to the same quarter last year. As a group, analysts predict that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, September 30th. Amdocs's dividend payout ratio (DPR) is 44.42%.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on DOX. Wall Street Zen lowered shares of Amdocs from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Wolfe Research initiated coverage on shares of Amdocs in a report on Tuesday, July 8th. They set an "outperform" rating on the stock. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $105.33.
Check Out Our Latest Research Report on Amdocs
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.